In some breast cancers, expression of MYB is enhanced by the presence of another transcription factor, oestrogen receptor alpha (ERα) [33], where a ligand–ERα complex is required to alleviate attenuated expression of MYB [34]. This evidence concerns the gene ESR1 and breast carcinoma.